000 | 01190 a2200325 4500 | ||
---|---|---|---|
005 | 20250513195821.0 | ||
264 | 0 | _c19991207 | |
008 | 199912s 0 0 eng d | ||
022 | _a0093-7754 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAdjei, A A | |
245 | 0 | 0 |
_aDocetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer. _h[electronic resource] |
260 |
_bSeminars in oncology _cOct 1999 |
||
300 |
_a32-40; discussion 41-2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIrinotecan |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 | _aTaxoids |
700 | 1 | _aArgiris, A | |
700 | 1 | _aMurren, J R | |
773 | 0 |
_tSeminars in oncology _gvol. 26 _gno. 5 Suppl 16 _gp. 32-40; discussion 41-2 |
|
999 |
_c10541186 _d10541186 |